GlassScriptPhysician profile
Sergey M Lipko
NPI 1972137966
$7,344.02
in general payments reported to CMS, 2019-2025
43 companies · $1,412 in 2025
The $1,412 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,582 · 2022: $1,788 · 2023: $1,394 · 2024: $1,168 · 2025: $1,412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,975.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,974.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,655.11 | 2021-2025 | Speedicath, Altis |
| Astellas Pharma US INC | $621.70 | 2021-2025 | Xtandi, Myrbetriq, Veozah |
| Antares Pharma, INC. | $568.91 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Janssen Biotech, INC. | $500.35 | 2021-2025 | Erleada, Akeega |
| Abbvie INC. | $454.66 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $303.18 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Rochester Medical Corporation | $295.82 | 2022 | |
| Urogen Pharma, INC. | $287.39 | 2022-2025 | Jelmyto |
| Pfizer INC. | $214.69 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $182.34 | 2023-2025 | Gemtesa |
| Axonics, INC. | $169.57 | 2024 | Axonics, Bulkamid |
| Ferring Pharmaceuticals INC. | $164.02 | 2024-2025 | Adstiladrin |
| Endo USA, INC. | $150.01 | 2025 | Xiaflex, Aveed |
| Dendreon Pharmaceuticals LLC | $143.18 | 2021-2025 | Provenge |
| Myovant Sciences INC. | $133.71 | 2021 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $132.98 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Boston Scientific Corporation | $126.33 | 2022-2025 | Ams 700, Watchman Flx, Lithovue |
| Clarus Therapeutics INC. | $108.90 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $102.79 | 2021-2023 | |
| Urovant Sciences INC | $90.61 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $87.07 | 2023-2025 | Pylarify |
| Tolmar, INC. | $80.85 | 2023-2025 | Eligard, Jatenzo |
| Genzyme Corporation | $75.30 | 2022 | |
| Medtronic, INC. | $66.37 | 2023-2025 | Interstim |
| C. R. Bard, INC. & Subsidiaries | $63.54 | 2025 | Magic3 Go Intermittent Urinary Catheter, Bard Urinary Drainage Bag |
| Tolmar Pharmaceuticals, INC. | $62.73 | 2021 | |
| Convatec INC. | $58.07 | 2021-2022 | |
| Halozyme INC | $52.09 | 2023 | |
| Abc Home Medical Supply, INC. | $51.65 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $44.83 | 2022 | |
| Olympus America INC. | $39.59 | 2022-2025 | Itind System |
| 180 Medical, INC. | $34.83 | 2024-2025 | Gentlecath Glide |
| Blue Earth Diagnostics | $31.14 | 2023-2024 | |
| Acerus Pharmaceuticals Corporation | $27.80 | 2021 | |
| Smith+Nephew, INC. | $26.53 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $21.58 | 2025 | Opdivo |
| Biotissue Holdings INC. | $21.23 | 2023 | |
| Baxter Healthcare | $18.97 | 2022 | |
| Novartis Pharmaceuticals Corporation | $17.87 | 2022 | |
| Davol INC. | $15.22 | 2025 | Arista |
| Endo Pharmaceuticals INC. | $14.67 | 2021 | |
| Hollister Incorporated | $13.47 | 2023 | Vapro, Onli, Infyna Chic |
| Allergan, INC. | $12.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergey Lipko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.